Stockscreener 앱 받기
0.23%
시간 외 거래:
전일 마감가:
$720.82
열려 있는:
$723.08
하루 거래량:
528.84K
Relative Volume:
0.54
시가총액:
$88.11B
수익:
$359.05B
순이익/손실:
$3.30B
주가수익비율:
27.81
EPS:
25.83
순현금흐름:
$5.23B
1주 성능:
-1.34%
1개월 성능:
+0.43%
6개월 성능:
+24.18%
1년 성능:
+18.98%
1일 변동 폭
$718.22
$727.06
1주일 범위
$708.15
$733.10
52주 변동 폭
$464.42
$733.10
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corporation
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
MCK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
718.41 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
292.32 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
163.75 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
72.79 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
7.86 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
맥케슨 Stock (MCK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-04 | 재개 | Mizuho | Neutral |
| 2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 재확인 | Leerink Partners | Outperform |
| 2024-08-08 | 재확인 | Mizuho | Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 재확인 | Barclays | Overweight |
| 2021-11-02 | 재확인 | BofA Securities | Buy |
| 2021-11-02 | 재확인 | Evercore ISI | Outperform |
| 2021-11-02 | 재확인 | Jefferies | Buy |
| 2021-03-30 | 업그레이드 | Argus | Hold → Buy |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-10-26 | 재확인 | Barclays | Equal Weight |
| 2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-02 | 재확인 | Mizuho | Neutral |
| 2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
McKesson Corporation (MCK) Surged Following a Decent Set of Results - Insider Monkey
Here's Why McKesson (MCK) is a Strong Value Stock - Yahoo Finance
Healthcare's Digital Dilemma Market to See Drastic GrowthPost - openPR.com
Why McKesson (MCK) is a Top Growth Stock for the Long-Term - Yahoo Finance
Morgan Stanley Hikes McKesson (MCK) Price Target on Earnings Growth Prospects - Insider Monkey
Wells Fargo Affirms McKesson (MCK) Equal Weight Rating and $766 Price Target - Insider Monkey
Leerink Partners Remains Bullish on McKesson Corporation (MCK), Retains a $785 Price Target - Insider Monkey
Here's How Much $100 Invested In McKesson 20 Years Ago Would Be Worth Today - Benzinga
McKesson (MCK) Rises Higher Than Market: Key Facts - Yahoo Finance
Stan Wong's Top Picks: iShares Silver Bullion ETF, McKesson & Nvidia - BNN Bloomberg
McKesson (NYSE:MCK) Price Target Raised to $770.00 at Morgan Stanley - Defense World
McKesson Adjusts Earnings Outlook Amid Pharma Growth - Finimize
McKesson Boosts Fiscal 2026 EPS Guidance on Operational Strength, Morgan Stanley Says - marketscreener.com
McKesson (MCK) Price Target Raised by Morgan Stanley | MCK Stock News - GuruFocus
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance
McKesson to Host Investor Day on September 23, 2025 - BioSpace
McKesson to Host Investor Day on September 23, 2025 | MCK Stock News - GuruFocus
McKesson (MCK) Revises Earnings Projections for Fiscal Year 2026 - GuruFocus
McKesson (MCK) Price Target Raised by Morgan Stanley to $770 | M - GuruFocus
McKesson price target raised to $770 from $745 at Morgan Stanley - TipRanks
McKesson (MCK) Revises Earnings Projections for Fiscal Year 2026 | MCK Stock News - GuruFocus
McKesson (MCK) Price Target Raised by Morgan Stanley to $770 | MCK Stock News - GuruFocus
Those who invested in McKesson (NYSE:MCK) five years ago are up 366% - simplywall.st
McKesson stock price target raised at Morgan Stanley on growth outlook - Investing.com India
Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel AdvisorsLeading key players (GE Healthcare, Oracle Health, Allscripts Healthcare Solutions, Siemens Heal - The Malaysian Reserve
McKesson Corporation (MCK) Updates Fiscal Year 2026 Financial Outlook - GuruFocus
McKesson CEO Tyler Brian S. sells shares for $13.67 million By Investing.com - Investing.com South Africa
McKesson CEO Tyler Brian S. sells shares for $13.67 million - Investing.com
McKesson Stock: Is Wall Street Bullish or Bearish? - MSN
Mckesson Says Executives To Meet With Investors And AnalystsSEC Filing - MarketScreener
McKesson Updates Fiscal Year 2026 Financial Outlook - TipRanks
McKesson Raises FY Earnings Outlook - MarketWatch
McKesson leads the charge in revolutionizing precision oncology in community practices - Endpoints News
McKesson Stock: Is MCK Outperforming the Healthcare Sector? - MSN
McKesson Corporation Acquires Florida Cancer Specialists Core Ventures to Expand Community-Based Oncology Care - geneonline.com
Wells Fargo Raises McKesson (MCK) Price Target, Maintains Equal Weight Rating - MSN
Mizuho Adjusts Price Target on McKesson to $735 From $690, Maintains Neutral Rating - marketscreener.com
3 Reasons We Love McKesson (MCK) - FinancialContent
McKesson Corporation Acquires Florida Cancer Specialists to Expand Community-Based Oncology Care - geneonline.com
McKesson Stock: Is MCK Outperforming The Healthcare Sector? - Barchart.com
McKesson completes acquisition of Core Ventures - Drug Store News
Wells Fargo & Company Issues Positive Forecast for McKesson (NYSE:MCK) Stock Price - Defense World
McKesson acquires majority stake in Core Ventures By Investing.com - Investing.com South Africa
McKesson Corporation (MCK) Finalizes Purchase of Core Ventures - Insider Monkey
McKesson (MCK): Wells Fargo Raises Price Target to $766 | MCK St - GuruFocus
McKesson Acquires 70% Stake In Core Ventures To Boost Community Oncology Access - Nasdaq
McKesson completes control acquisition of cancer care clinics for $2.5B - The Business Journals
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
0.15%
자본화:
|
볼륨(24시간):